首页> 外文OA文献 >Analysis of chlormequat in human urine as a biomarker of exposure using liquid chromatography triple quadrupole mass spectrometry.
【2h】

Analysis of chlormequat in human urine as a biomarker of exposure using liquid chromatography triple quadrupole mass spectrometry.

机译:用液相色谱三重四极杆质谱法分析人体尿液中的矮壮素作为暴露的生物标志物。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In this study, a method using liquid chromatography triple quadrupole mass spectrometry (LC/MS/MS) is described for the analysis of the plant growth regulator chlormequat (CCC) in human urine. Analysis was carried out using selected reaction monitoring (SRM) in the positive ion mode. [(2)H(4)] labeled CCC as internal standard (IS) was used for quantification of CCC. The limit of detection (LOD) was determined to 0.1ng/mL. The method was linear in the range 0.3-800ng/mL urine and had a within-run precision of 4-9%. The between-run precision was determined at urine levels of 7.0 and 31ng/mL and found to be 5 and 6% respectively. The reproducibility was 3-6%. To validate CCC as a biomarker of exposure, the method was applied in a human experimental oral exposure to CCC. Two healthy volunteers received 25μg/kg b.w. CCC in a single oral dose followed by urine sampling for 46h post-exposure. The CCC was estimated to follow a first order kinetic and a two compartment model with an elimination half-life of 2-3h and 10-14h respectively. One hundred 24h urine samples were collected from non-occupationally exposed individuals in the general population in southern Sweden. All samples had detectable levels above the LOD 0.1ng/mL urine. The median levels were 4ng/mL of CCC in unadjusted urine. The levels found in the population samples are several magnitudes lower than those found in the experimental exposure, which corresponds to an oral exposure of 50% of the ADI for CCC.
机译:在这项研究中,描述了一种使用液相色谱三重四极杆质谱(LC / MS / MS)的方法来分析人尿中的植物生长调节剂百草枯(CCC)。使用选定的反应监测(SRM)以正离子模式进行分析。 [(2)H(4)]标记的CCC作为内标(IS)用于定量CCC。检测限(LOD)确定为0.1ng / mL。该方法在尿液0.3-800ng / mL范围内是线性的,运行内精密度为4-9%。在7.0和31ng / mL的尿液水平下测定两次运行之间的精确度,分别为5和6%。重现性为3-6%。为了验证CCC作为暴露的生物标志物,该方法被用于人类实验性CCC口服暴露。两名健康志愿者的体重为25μg/ kg体重。一次口服CCC,然后在暴露后46h进行尿液采样。估计CCC遵循一阶动力学模型和两室模型,消除半衰期分别为2-3h和10-14h。从瑞典南部普通人群的非职业暴露人群中收集了一百二十四小时的尿液样本。所有样品的可检测水平都高于LOD 0.1ng / mL尿液。未经调整的尿液中位CCC的中位数为4ng / mL。总体样本中发现的水平比实验暴露中发现的水平低几个数量级,这相当于CCC口服ADI的50%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号